Latest news 17th September 2025 NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy 23rd June 2025 Drug Developer Mabion, Releases First Batch of Novalgen’s Next-Generation T-CELL Engager, NVG-222 for First In-Human Clinical Trials. VIEW ALL NEWS Publications Read our publications here VIEW ALL PUBLICATIONS
17th September 2025 NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy
23rd June 2025 Drug Developer Mabion, Releases First Batch of Novalgen’s Next-Generation T-CELL Engager, NVG-222 for First In-Human Clinical Trials.
